MAPKs activation in head and neck squamous cell carcinomas
Cancer of head and neck (HN) represents a diffused group of neoplasia; despite advances in clinical treatment its mortality rate has remained high, mainly because it is frequently diagnosed only at an advanced stage. Molecular markers allowing the diagnosis at an early stage would be useful. Mitogen...
Main Authors: | Daniele Maggioni, Renato Gaini, Gabriella Nicolini, Giovanni Tredici, Werner Garavello |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-11-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | http://www.oncologyreviews.org/index.php/or/article/view/37 |
Similar Items
-
Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein
by: Hossein Heydar, et al.
Published: (2018-04-01) -
Antimetastatic Effects of Sesamin on Human Head and Neck Squamous Cell Carcinoma through Regulation of Matrix Metalloproteinase-2
by: Jian-Ming Chen, et al.
Published: (2020-05-01) -
Basaloid squamous cell carcinoma of the head and neck: Our experience
by: Jaimanti Bakshi, et al.
Published: (2020-01-01) -
Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01) -
Prognostic Significance of MMP2 and MMP9 Functional Promoter Single Nucleotide Polymorphisms in Head and Neck Squamous Cell Carcinoma
by: Samaneh Hajihoseini, et al.
Published: (2011-03-01)